DE69934239D1 - Ly6h-gen - Google Patents
Ly6h-genInfo
- Publication number
- DE69934239D1 DE69934239D1 DE69934239T DE69934239T DE69934239D1 DE 69934239 D1 DE69934239 D1 DE 69934239D1 DE 69934239 T DE69934239 T DE 69934239T DE 69934239 T DE69934239 T DE 69934239T DE 69934239 D1 DE69934239 D1 DE 69934239D1
- Authority
- DE
- Germany
- Prior art keywords
- gene
- ly6h
- gen
- expression vector
- product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Physics & Mathematics (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP26355098 | 1998-09-17 | ||
JP26355098 | 1998-09-17 | ||
PCT/JP1999/005039 WO2000017345A1 (fr) | 1998-09-17 | 1999-09-16 | Gene ly6h |
Publications (3)
Publication Number | Publication Date |
---|---|
DE69934239D1 true DE69934239D1 (de) | 2007-01-11 |
DE69934239T2 DE69934239T2 (de) | 2007-06-28 |
DE69934239T8 DE69934239T8 (de) | 2007-12-06 |
Family
ID=17391112
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69934239T Active DE69934239T8 (de) | 1998-09-17 | 1999-09-16 | Ly6h-gen |
Country Status (17)
Country | Link |
---|---|
US (4) | US7432363B2 (de) |
EP (1) | EP1114861B8 (de) |
JP (1) | JP4403443B2 (de) |
KR (1) | KR100640265B1 (de) |
CN (1) | CN1240834C (de) |
AT (1) | ATE346923T1 (de) |
AU (1) | AU767878B2 (de) |
BR (1) | BR9913850A (de) |
CA (1) | CA2342770C (de) |
CY (1) | CY1107552T1 (de) |
DE (1) | DE69934239T8 (de) |
DK (1) | DK1114861T3 (de) |
ES (1) | ES2276531T3 (de) |
HK (1) | HK1038380A1 (de) |
ID (1) | ID29573A (de) |
PT (1) | PT1114861E (de) |
WO (1) | WO2000017345A1 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE346923T1 (de) * | 1998-09-17 | 2006-12-15 | Otsuka Pharma Co Ltd | Ly6h-gen |
US20030211040A1 (en) * | 2001-08-31 | 2003-11-13 | Paul Greengard | Phosphodiesterase activity and regulation of phosphodiesterase 1B-mediated signaling in brain |
DE10303974A1 (de) | 2003-01-31 | 2004-08-05 | Abbott Gmbh & Co. Kg | Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung |
DK1976877T4 (en) | 2005-11-30 | 2017-01-16 | Abbvie Inc | Monoclonal antibodies to amyloid beta protein and uses thereof |
KR20080090408A (ko) | 2005-11-30 | 2008-10-08 | 아보트 러보러터리즈 | 항-Aβ 글로불로머 항체, 이의 항원-결합 잔기, 상응하는하이브리도마, 핵산, 벡터, 숙주 세포, 당해 항체의 제조방법, 당해 항체를 포함하는 조성물, 당해 항체의 용도 및당해 항체의 사용 방법 |
US8455626B2 (en) | 2006-11-30 | 2013-06-04 | Abbott Laboratories | Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
WO2008103962A2 (en) * | 2007-02-22 | 2008-08-28 | Genentech, Inc. | Methods for detecting inflammatory bowel disease |
US20100311767A1 (en) | 2007-02-27 | 2010-12-09 | Abbott Gmbh & Co. Kg | Method for the treatment of amyloidoses |
EP2461673A4 (de) | 2009-08-05 | 2013-08-07 | Intra Cellular Therapies Inc | Neue regulatorproteine und hemmer |
JP2013523182A (ja) | 2010-04-15 | 2013-06-17 | アボット・ラボラトリーズ | アミロイドベータ結合タンパク質 |
CN105348387B (zh) | 2010-08-14 | 2020-08-25 | Abbvie 公司 | β淀粉样蛋白结合蛋白 |
US20140286910A1 (en) * | 2013-03-19 | 2014-09-25 | Nikolai Tankovich | Stem cells and methods incorporating environmental factors as a means for enhancing stem cell proliferation and plasticity |
CN105385754B (zh) * | 2015-10-28 | 2018-11-06 | 北京泱深生物信息技术有限公司 | 一种与胆管癌相关的分子标记物 |
KR102232200B1 (ko) * | 2019-03-13 | 2021-03-25 | 아주대학교산학협력단 | 알츠하이머치매 진단 바이오마커 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5011912A (en) | 1986-12-19 | 1991-04-30 | Immunex Corporation | Hybridoma and monoclonal antibody for use in an immunoaffinity purification system |
JPH0348696A (ja) * | 1989-07-14 | 1991-03-01 | Toray Ind Inc | ヒトリンパ球表面抗原およびそれをコードする遺伝子 |
AU4594696A (en) * | 1995-11-13 | 1997-06-05 | Human Genome Sciences, Inc. | Human stem cell antigen 2 |
AU2095299A (en) * | 1997-12-31 | 1999-07-19 | Incyte Pharmaceuticals, Inc. | Human signal peptide-containing proteins |
ATE346923T1 (de) * | 1998-09-17 | 2006-12-15 | Otsuka Pharma Co Ltd | Ly6h-gen |
-
1999
- 1999-09-16 AT AT99943357T patent/ATE346923T1/de active
- 1999-09-16 JP JP2000574245A patent/JP4403443B2/ja not_active Expired - Fee Related
- 1999-09-16 AU AU56518/99A patent/AU767878B2/en not_active Ceased
- 1999-09-16 BR BR9913850-6A patent/BR9913850A/pt not_active Application Discontinuation
- 1999-09-16 CN CNB998110191A patent/CN1240834C/zh not_active Expired - Fee Related
- 1999-09-16 PT PT99943357T patent/PT1114861E/pt unknown
- 1999-09-16 WO PCT/JP1999/005039 patent/WO2000017345A1/ja active IP Right Grant
- 1999-09-16 ID IDW20010739A patent/ID29573A/id unknown
- 1999-09-16 CA CA2342770A patent/CA2342770C/en not_active Expired - Fee Related
- 1999-09-16 ES ES99943357T patent/ES2276531T3/es not_active Expired - Lifetime
- 1999-09-16 DK DK99943357T patent/DK1114861T3/da active
- 1999-09-16 KR KR1020017003354A patent/KR100640265B1/ko not_active IP Right Cessation
- 1999-09-16 EP EP99943357A patent/EP1114861B8/de not_active Expired - Lifetime
- 1999-09-16 DE DE69934239T patent/DE69934239T8/de active Active
-
2001
- 2001-12-28 HK HK01109195A patent/HK1038380A1/xx not_active IP Right Cessation
-
2003
- 2003-12-23 US US10/743,018 patent/US7432363B2/en not_active Expired - Fee Related
-
2007
- 2007-02-02 CY CY20071100152T patent/CY1107552T1/el unknown
-
2008
- 2008-02-15 US US12/032,012 patent/US20090017479A1/en not_active Abandoned
- 2008-07-03 US US12/167,288 patent/US7582732B2/en not_active Expired - Fee Related
- 2008-09-30 US US12/242,370 patent/US20100261880A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN1318099A (zh) | 2001-10-17 |
EP1114861A4 (de) | 2004-10-13 |
US20090017479A1 (en) | 2009-01-15 |
WO2000017345A1 (fr) | 2000-03-30 |
DE69934239T8 (de) | 2007-12-06 |
US20100261880A1 (en) | 2010-10-14 |
US20040254340A1 (en) | 2004-12-16 |
AU5651899A (en) | 2000-04-10 |
EP1114861A1 (de) | 2001-07-11 |
CA2342770C (en) | 2011-06-21 |
DE69934239T2 (de) | 2007-06-28 |
US20080275218A1 (en) | 2008-11-06 |
ES2276531T3 (es) | 2007-06-16 |
ID29573A (id) | 2001-09-06 |
ATE346923T1 (de) | 2006-12-15 |
EP1114861B1 (de) | 2006-11-29 |
DK1114861T3 (da) | 2007-03-19 |
US7432363B2 (en) | 2008-10-07 |
KR100640265B1 (ko) | 2006-10-31 |
BR9913850A (pt) | 2001-10-23 |
JP4403443B2 (ja) | 2010-01-27 |
US7582732B2 (en) | 2009-09-01 |
HK1038380A1 (en) | 2002-03-15 |
AU767878B2 (en) | 2003-11-27 |
CN1240834C (zh) | 2006-02-08 |
CY1107552T1 (el) | 2013-03-13 |
CA2342770A1 (en) | 2000-03-30 |
KR20010085801A (ko) | 2001-09-07 |
EP1114861B8 (de) | 2008-10-01 |
PT1114861E (pt) | 2007-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1107552T1 (el) | Ly6h γονιδιο | |
DE69636866D1 (en) | Reverse "two-hybrid"-systeme | |
WO1999053061A3 (en) | Tumor associated nucleic acids and uses therefor | |
DK1005540T3 (da) | IKK-beta-proteiner, nukleinsyrer og fremgangsmåder | |
CY1106806T1 (el) | Dna και πολυπεπτιδια ανθρωπινης tslp | |
EP0804609A4 (de) | NEUARTIGE AUF p53 ANSPRECHENDE GENE | |
DE69839444D1 (de) | Smad 6 und dessen anwendungen | |
DE69635207D1 (de) | Auf Chromosom 1 lokalisiertes Gen dessen Genprodukt mit der Alzheimerschen Krankheit assoziiert ist. | |
IL135688A0 (en) | Human checkpoint kinase, hcds1, compositions and methods | |
WO2002004677A3 (en) | Methods for diagnosis and treatment of psychiatric disorders | |
IL122884A0 (en) | Enamel matrix related polypeptide | |
AU2001238064A1 (en) | 18477, a human protein kinase and uses therefor | |
DE69839765D1 (de) | Lage-1 tumor-assozierte nukleinsäuren | |
EP0816498A3 (de) | Exzitatorische Aminosäure Rezeptor-Protein und verwante Nukleinsäure | |
EP0723014A3 (de) | cDNA des DOCK180 Gens und DOCK180 Protein | |
WO2004003170A3 (en) | Agents capable of inhibiting ras and uses thereof | |
WO2000008143A3 (de) | Gen isoliert auf dem kurzen arm des menschlichen chromosoms 17 | |
IL142664A0 (en) | Prv-1 gene, processes for detecting the prv-1 polypeptide and pharmaceutical compositions containing the same | |
EP1219706A3 (de) | Verfahren zur Herstellung von rekombinanterAsparaginase aus Wollinella Succinogenes | |
DE69519654D1 (de) | htFIIIA Gen | |
AU2002350406A1 (en) | Identification of ses-3 (spr-5) in c. elegans and the uses of the same | |
WO2003000889A3 (de) | Identifizierung von ses-1 aus c. elegans sowie dessen verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8381 | Inventor (new situation) |
Inventor name: HORIE, MASATO, NARUTO-SHI, TOKUSHIMA, JP Inventor name: OKUTOMI, KEIICHI, YACHIYO-SHI, CHIBA, JP Inventor name: TANIGUCHI, YOSHIHIRO, TOKUSHIMA, JP Inventor name: SUZUKI, MIKIO, TOKUSHIMA, JP Inventor name: OHBUCHI, YUTAKA, TOKUSHIMA, JP |
|
8364 | No opposition during term of opposition |